Perindoprilat

Perindoprilat (S 9780) is an angiotensin-converting enzyme (ACE) inhibitor with the IC50 value ranging from 1.5 to 3.2 nM. Perindoprilat can be used in hypertension research[1][2].

Product Specifications

CAS Number

[95153-31-4]

Product Name Alternative

S 9780

UNSPSC

12352005

Hazard Statement

H302, H312, H332

Target

Angiotensin-converting Enzyme (ACE)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/perindoprilat.html

Purity

99.60

Solubility

DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 175 mg/mL (ultrasonic)

Smiles

O=C([C@H]1N(C([C@@H](N[C@H](C(O)=O)CCC)C)=O)[C@@]2([H])CCCC[C@@]2([H])C1)O

Molecular Formula

C17H28N2O5

Molecular Weight

340.41

Precautions

H302, H312, H332

References & Citations

[1]Perindopril. Expert Opin Pharmacother. 2006 Jan;7 (1) :63-71.|[2]Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol. 2007 Dec 22;577 (1-3) :1-6.|[3]Izabella Z A Pawluczyk, et al. The role of bradykinin in the antifibrotic actions of perindoprilat on human mesangial cells. Kidney Int. 2004 Apr;65 (4) :1240-51.|[4]X-Z Wang, et al. Perindopril inhibits myocardial apoptosis in mice with acute myocardial infarction through TLR4/NF-κB pathway. Eur Rev Med Pharmacol Sci. 2019 Aug;23 (15) :6672-6682.